These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 28918421
1. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report. Tulbă D, Balea M, Băicuş C. Rom J Intern Med; 2018 Mar 01; 56(1):67-70. PubMed ID: 28918421 [Abstract] [Full Text] [Related]
2. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases]. Luo ZJ, Wu JJ, Song Y, Mei CL, DU R. Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):1111-1117. PubMed ID: 38101797 [Abstract] [Full Text] [Related]
3. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients. Wafa A, Hicham H, Naoufal R, Hajar K, Rachid R, Souad B, Mouna M, Zoubida MT, Mohamed A. Clin Rheumatol; 2022 Jul 18; 41(7):2021-2033. PubMed ID: 35179662 [Abstract] [Full Text] [Related]
9. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, Chiang BL. Clin Rheumatol; 2012 Aug 18; 31(8):1223-30. PubMed ID: 22615046 [Abstract] [Full Text] [Related]
13. Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report. Tomofuji Y, Ishikawa Y, Hattori K, Fujiwara M, Kita Y. Mod Rheumatol Case Rep; 2020 Jul 18; 4(2):222-228. PubMed ID: 33087000 [Abstract] [Full Text] [Related]
14. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China. Liu AC, Yang Y, Li MT, Jia Y, Chen S, Ye S, Zeng XZ, Wang Z, Zhao JX, Liu XY, Zhu J, Zhao Y, Zeng XF, Li ZG. Clin Rheumatol; 2018 Jan 18; 37(1):93-100. PubMed ID: 28409239 [Abstract] [Full Text] [Related]
15. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus. Cohen EM, D'Silva K, Kreps D, Son MB, Costenbader KH. Lupus; 2018 Jun 18; 27(7):1065-1071. PubMed ID: 29451069 [Abstract] [Full Text] [Related]